IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Opus Point Partners Management, LLC

Portfolio Profile

CIK: 0001600175 | New York, NY

$3.4M
AUM
54
Positions
99.28%
Top 10 Conc.
99.7%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Alnylam Pharmaceuticals Inc(ALNY)13,684$1.1M32.59%
2Biomarin Pharmaceutical Inc(BMRN)9,700$654.0K19.38%
3Ascendis Pharma A S(ASND)6,190$596.0K17.66%
4Acadia Pharmaceuticals Inc(ACAD)12,005$432.0K12.80%
5Charles RIV Labs Intl Inc(CRL)2,112$280.0K8.30%
6Biogen Inc(BIIB)1,123$261.0K7.73%
7Ishares TR(IBB)125,000$12.4K0.37%
8Direxion SHS ETF TR(LABUUSD)99,855$3.1K0.09%
9Mettler Toledo International(MTD)3,235$2.3K0.07%
10Bristol Myers Squibb Co(BMY)33,000$1.7K0.05%

Sector Allocation

Latest filing, equity positions only

Healthcare99.13% · $3.3M
Unclassified0.87% · $29.2K

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare99.02%99.13%+0.11%
Unclassified0.98%0.87%-0.11%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$12.0M | 57 pos.
$16.3M | 67 pos.
$9.9M | 67 pos.
$14.1M | 63 pos.
$12.1M | 65 pos.
$6.7M | 51 pos.
Cap SizePrev %Curr %Change
Large Cap75.42%77.91%+2.49%
Mid Cap16.98%21.19%+4.21%
Unclassified0.98%0.87%-0.11%
Small Cap6.62%0.02%-6.6%
Micro Cap0.01%0.01%0%
$6.2M | 50 pos.
$5.3M | 47 pos.
$3.0M | 40 pos.
$4.5M | 75 pos.
$3.7M | 63 pos.
$3.4M | 55 pos.
Q4
16
Q1
17
Q2
17
Q3
17
Q4
17
Q1
18
Q2
18
Q3
18
Q4
18
Q1
19
Q2
19
Q3
19

Recent Activity

Quarter-over-quarter position changes

2
New
10
Closed
18
Increased
1
Decreased
34
Unchanged